Literature DB >> 31311447

Ulinastatin attenuates isoflurane-induced cognitive dysfunction in aged rats by inhibiting neuroinflammation and β-amyloid peptide expression in the brain.

Mingyan Guo1, Xiaoqiu Zhu1, Hui Xu1, Jin Li1, Shangze Yang2, Zhiyi Zuo1,3, Daowei Lin1.   

Abstract

Objective: Postoperative neurocognitive disease (PNCD) in the aged is a major clinical problem with unclear mechanisms. This study was designed to explore the mechanisms for ulinastatin (UTI) to attenuate isoflurane-induced cognitive decline in Fischer-344 rats.
Methods: The rats were divided into four groups: Control (0.9% saline only), Isoflurane (exposure to 1.2% isoflurane), Isoflurane-plus-UTI (exposure to 1.2% isoflurane followed by 100,000 U/kg UTI injection i.v.) and UTI-plus-isoflurane (i.v. of 100,000 U/kg UTI followed by 1.2% isoflurane exposure). After respective tests, the concentrations of tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in the brain were determined by ELISA the expression of β-amyloid peptide (Aβ) and cleaved caspase-3 were measured by Western blot. Ratio of apoptotic cells after Barnes maze challenge was assessed by TUNEL assay.
Results: In both Barnes Maze training and challenge, results indicated isoflurane-impaired learning capacity, while pre-and post-treatment with UTI could attenuate this phenomenon. The ratio of apoptotic cells and the expression of cleaved caspase-3 were increased after isoflurane exposure, indicating that isoflurane could induce neuronal apoptosis, while both pre- and post-treatment with UTI could diminish these effects. Moreover, UTI inhibited the expression of TNF-α, IL-1β and Aβ induced by isoflurane in rat brain harvested at 16 h after isoflurane exposure.
Conclusion: These results suggest that UTI inhibits neuronal apoptosis in rat brain by attenuating increased expression of Aβ42 and inflammatory cytokines, which may contribute to its alleviation of isoflurane-induced cognitive dysfunction in rats. Moreover, UTI pre-treatment before isoflurane exposure showed more effective than post-treatment.

Entities:  

Keywords:  Ulinastatin; inflammatory cytokine; isoflurane; postoperative neurocognitive disease; β-amyloid peptide

Mesh:

Substances:

Year:  2019        PMID: 31311447     DOI: 10.1080/01616412.2019.1642564

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  5 in total

1.  Salubrious effects of ulinastatin and quercetin alone or in combination in endothelial dysfunction and vascular dementia.

Authors:  Poonam Sharma; Nikita Gaur; Shalini Jayant; B M Sharma; Bhagwat Singh; Harsha Kharkwal; Bhupesh Sharma
Journal:  Pharmacol Rep       Date:  2022-04-09       Impact factor: 3.024

2.  Intranasal levosimendan prevents cognitive dysfunction and apoptotic response induced by repeated isoflurane exposure in newborn rats.

Authors:  Serdar Demirgan; Onat Akyol; Zeynep Temel; Aslıhan Şengelen; Murat Pekmez; Ozancan Ulaş; Mehmet Salih Sevdi; Kerem Erkalp; Ayşin Selcan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-03-27       Impact factor: 3.000

3.  Protective effects of chlorogenic acid on isoflurane-induced cognitive impairment of aged mice.

Authors:  Hao Chong; Yang Xi; Yan Zhou; Geng Wang
Journal:  Food Sci Nutr       Date:  2022-06-20       Impact factor: 3.553

4.  Effect of Ulinastatin Combined with Xingnaojing Injection on Severe Traumatic Craniocerebral Injury and Its Influence on Oxidative Stress Response and Inflammatory Response.

Authors:  Zexin An; Yong Yin; Lei Zhang; Bo Wang; Tao Cui; Meng Li; Jianwei Zhuo; Jing Zhang; Kai Wang; Wenwen Zhang; Meng Ji; Jilin Sun; Yinong Xu
Journal:  Biomed Res Int       Date:  2022-01-10       Impact factor: 3.411

5.  Efficacy of Ulinastatin and Sulforaphane Alone or in Combination in Rat Model of Streptozotocin Diabetes Induced Vascular Dementia.

Authors:  Poonam Sharma; Prachi Kaushik; Swati Jain; Brij Mohan Sharma; Rajendra Awasthi; Giriraj Thirupathirao Kulkarni; Bhupesh Sharma
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-08-31       Impact factor: 2.582

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.